Flemington Pharmaceutical Corporation Announces Patent Issuance.Business, Legal & Health/Medical Editors FLEMINGTON, N.J.--(BUSINESS WIRE)--Sept. 7, 2000 Flemington Pharmaceutical Corporation (Flemington or the Company) (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: "FLEM, FLEMw") announced today issuance of U. S. Patent No. 6,110,486 for its validated Immediate-Immediate Release (I2R I2R Institute for Infocomm Research I2R Imaging Infrared (TM)) lingual spray delivery system for the administration of antihistamines Antihistamines Definition Antihistamines are drugs that block the action of histamine (a compound released in allergic inflammatory reactions) at the H1 , steroid hormones, non-steroidal anti-inflammatories, alkaloids alkaloids, n alkaline phytochemicals that contain nitrogen in a heterocyclic ring structure. They can have powerful pharmacological effects and are more often used in traditional medicine than in herbal treatments. , benzodiazepines Benzodiazepines Definition Benzodiazepines are medicines that help relieve nervousness, tension, and other symptoms by slowing the central nervous system. Purpose Benzodiazepines are a type of antianxiety drugs. , analgesics and anti-depressants. The patent covers the delivery of these classes of drugs in polar solvents. Dr. Harry A. Dugger III, President of the Company stated that in his opinion, the pilot studies already carried out by the Company on nicotine, clemastine, estradiol, progesterone and nitroglycerin nitroglycerin (nī'trōglĭs`ərĭn), C3H5N3O9, colorless, oily, highly explosive liquid. It is the nitric acid triester of glycerol and is more correctly called glycerol trinitrate. have verified the ability of the Company's lingual spray delivery system to delivery therapeutic levels of medication to the body rapidly and at lower dosages. Flemington is engaged in the development of novel application drug delivery systems for presently marketed prescription and over-the-counter drugs. The novel delivery systems include lingual sprays and gelatin gelatin or animal jelly, foodstuff obtained from connective tissue (found in hoofs, bones, tendons, ligaments, and cartilage) of vertebrate animals by the action of boiling water or dilute acid. bite capsules. The Company believes that these delivery systems offer (i) improved drug safety by reducing the required drug dosage, therefore, reducing the side effects; (ii) improved dosage reliability; (iii) improved patient convenience and compliance; and (iv) enhanced dosage reliability. The Company plans to develop such products through collaborate arrangements with major pharmaceutical companies. For further information visit our web site: www.flemington-pharma.com Note: Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's Prospectus, dated Nov. 19, 1997, filed with the Securities and Exchange Commission. In assessing forward-looking statements contained herein, if any, reader is urged to carefully read all cautionary statements contained in that filing with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion